michael-type acceptor reactivity toward glutathione Thiol-Michael addition based conjugate for activation and release Michael Addition Reaction Mechanism -
Description
Thus, we have demonstrated that GSH-targeted therapy selectively kills PC cells in an oxidative stress-dependent manner and that the differences in basal ROS level and antioxidant scavenging capacity induced by stratified expression of VRK2 can well account for the heterogeneous sensitivity to GSH inhibition
Mt in gii khi tp th dc cng cao c th gy mt mi hoc cc vn nghim trng
73 imekS.KaraboaM
doi: 10.1189/jlb.0409236 96 MorhardtTLHayashiAOchiTQuirsMKitamotoSNagao-KitamotoHet al
